Treatment of Hidradenitis Suppurativa Using Etanercept

A Study of the Safety of INCB054707 in Participants With Hidradenitis Suppurativa

NCT03569371 ·Status: COMPLETED ·Phase: PHASE2

A 16-Week Study to Learn About the Study Medicine Called Ritlecitinib in Adults With Long Lasting Painful Red Skin Lumps, Known by the Medical Term, Hidradenitis Suppurativa, or HS.

NCT07228390 ·Status: RECRUITING ·Phase: PHASE2

Anakinra as a Treatment for Hydradenitis Suppurativa

NCT01516749 ·Status: COMPLETED ·Phase: PHASE2

A Proof of Concept Study to Evaluate the Effectiveness of Ustekinumab in Hidradenitis Suppurativa

NCT01704534 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Efalizumab in the Treatment of Moderate-Severe Hydradenitis Suppurativa

NCT00134134 ·Status: COMPLETED ·Phase: PHASE1

A Placebo-Controlled Study of the Safety of INCB054707 in Participants With Hidradenitis Suppurativa

NCT03607487 ·Status: COMPLETED ·Phase: PHASE2

Hidradenitis Suppurativa Patient Experience With Humira Treatment

NCT04132388 ·Status: WITHDRAWN ·Phase: PHASE4

Observational Study Evaluating Long-Term Safety and Effectiveness of Humira in Patients With Hidradenitis Suppurativa

NCT03894956 ·Status: COMPLETED

Study to Assess the Safety and Efficacy of Infliximab to Treat Hidradenitis Suppurtativa

NCT00795574 ·Status: COMPLETED ·Phase: PHASE2

Hidradenitis Suppurativa Phase 2b Study of Izokibep

NCT05355805 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate of the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa

NCT05635838 ·Status: COMPLETED ·Phase: PHASE2

Study of Heparin Prophylaxis of Hereditary Angioedema Exacerbations

NCT00004694 ·Status: COMPLETED ·Phase: NA

Topical Ruxolitinib 1.5% for Hidradenitis Suppurativa Treatment

NCT04414514 ·Status: TERMINATED ·Phase: PHASE2

A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa

NCT04242498 ·Status: COMPLETED ·Phase: PHASE3

A Single Center, Prospective Clinical Trial of Intravenous Ertapenem in the Treatment of Hurley Stage II or III Hidradenitis Suppurativa

NCT05255575 ·Status: WITHDRAWN

Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa (TRuE-HS2)

NCT06958211 ·Status: RECRUITING ·Phase: PHASE3

A Study Evaluating BFB759 in Moderate to Severe Hidradenitis Suppurativa

NCT07287644 ·Status: RECRUITING ·Phase: PHASE2/PHASE3

Biomarkers in Participants With Hidradenitis Suppurativa Receiving Guselkumab.

NCT04084665 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1

Subcutaneous Treatment With Icatibant for Acute Attacks of Hereditary Angioedema

NCT00097695 ·Status: COMPLETED ·Phase: PHASE3

Studying Complement Inhibition in Patients With Moderate to Severe Hidradenitis Suppurativa

NCT03001622 ·Status: COMPLETED ·Phase: PHASE2

A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa

NCT06468228 ·Status: RECRUITING ·Phase: PHASE3

Hidradenitis Suppurativa Study of Izokibep

NCT05905783 ·Status: TERMINATED ·Phase: PHASE3

A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa

NCT04242446 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Efficacy and Safety of Subcutaneous Sonelokimab Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

NCT06411899 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Study to Test the Long-term Treatment of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa

NCT04901195 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3